Tectonic Therapeutic | AVRO - Net Income

Stock Price
24.00
Daily Change
0.78 3.36%
Monthly
16.62%
Yearly
-43.66%
Q1 Forecast
19.37

Tectonic Therapeutic reported $-19.04M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Alnylam Pharmaceuticals USD 251.08M 317.36M Sep/2025
Celltrion KRW 331.35B 270.18B Sep/2025
Cspc Pharmaceutical CNY 963.54M 106.35M Sep/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 6.89B 1.44B Sep/2025
Gilead Sciences USD 3.05B 1.09B Sep/2025
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
MacroGenics USD 16.82M 53.07M Sep/2025
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -105K 409K Jun/2025
Neuren Pharmaceuticals AUD 7.52M 126.51M Jun/2025
Organigram Holdings CAD -37.96M 31.67M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Pharma Mar EUR -4.1M 27.47M Sep/2025
Qiagen NV USD 130.04M 33.79M Sep/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Sarepta Therapeutics USD -179.95M 376.84M Sep/2025
Sartorius EUR 43.8M 11.3M Sep/2025
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Takeda JPY 103.64B 115.44B Dec/2025
Tilray USD -44.93M 44.61M Sep/2025
Zz Pientze Pharmaceu CNY 687.04M 244.51M Sep/2025